Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Combining a Smartphone App With Medications to Manage Heavy Drinking

NCT06303778 · View on ClinicalTrials.gov ↗

Study Summary

One in 10 Veterans have an alcohol use disorder. However, few Veterans receive evidenced-based psychosocial interventions or medications to treat alcohol use disorder. Barriers to receiving these treatments include long wait times, stigma, and long distances from treatment facilities. Even fewer Veterans receive psychosocial and medication interventions together, despite clinical practice guidelines recommending both and evidence of better outcomes. Expanding access to these treatments in primary care is a VA priority but delivering psychosocial interventions is difficult in this setting, and medication is often the only option. Smartphone apps that deliver alcohol interventions may improve drinking outcomes and ensure Veterans can receive both treatments in primary care. This study will determine whether medications and an app for alcohol use problems offered to Veterans in primary care results in improved drinking outcomes, compared to Veterans receiving medications only. Study data will inform how to spread the app across the VA nationally.

Conditions Studied

Interventions

  • OTHER Standard Care
  • OTHER Stand Down mobile app

Study Locations (15)

Georgia

  • Atlanta VA Medical and Rehab Center, Decatur, GA — Decatur
  • Carl Vinson VA Medical Center, Dublin, GA — Dublin

Texas

  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX — Dallas
  • South Texas Health Care System, San Antonio, TX — San Antonio

Arizona

  • Phoenix VA Health Care System, Phoenix, AZ — Phoenix

Arkansas

  • Veterans Health Care System of the Ozarks, Fayetteville, AR — Fayetteville

District of Columbia

  • Washington DC VA Medical Center, Washington, DC — Washington D.C.

Florida

  • North Florida/South Georgia Veterans Health System, Gainesville, FL — Gainesville

Michigan

  • Battle Creek VA Medical Center, Battle Creek, MI — Battle Creek

Minnesota

  • Minneapolis VA Health Care System, Minneapolis, MN — Minneapolis

Trial Details

FieldValue
Enrollment Target 330 participants
Start Date 2024-11-01
Est. Completion 2028-11-01
Phase NA

Sponsor

VA Office of Research and Development

1,863 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06303778

The ClinicalTrials.gov registry entry for NCT06303778 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,863 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Alcohol Use Disorder (AUD) appearing as the primary indexed condition, and to 2 interventions — of which Standard Care is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06303778 reports 15 study locations spanning 13 distinct geographic areas — top geographies include Georgia, Texas, Arizona. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06303778 about?

NCT06303778 is a clinical study titled "Combining a Smartphone App With Medications to Manage Heavy Drinking". One in 10 Veterans have an alcohol use disorder. However, few Veterans receive evidenced-based psychosocial interventions or medications to treat alcohol use disorder. Barriers to receiving these treatments include long wait times, stigma, and long distances from treatment facilities. Even fewer Vet...

What is the current status of trial NCT06303778?

This trial is currently recruiting. It is a NA study. The enrollment target is 330 participants. The study started on 2024-11-01. Estimated completion is 2028-11-01.

What conditions does trial NCT06303778 study?

This clinical trial studies the following conditions: Alcohol Use Disorder (AUD). These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06303778?

The interventions under investigation include: Standard Care (OTHER), Stand Down mobile app (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06303778?

This trial is sponsored by VA Office of Research and Development, which has 1,863 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06303778 being conducted?

This trial has 15 study locations across Arizona, Arkansas, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial